Detalhe da pesquisa
1.
Targeting TBK1 to overcome resistance to cancer immunotherapy.
Nature
; 615(7950): 158-167, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634707
2.
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
N Engl J Med
; 388(1): 44-54, 2023 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36546659
3.
Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
J Natl Compr Canc Netw
; 22(3)2024 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503041
4.
Zolbetuximab plus chemotherapy for locally advanced unresectable or metastatic stomach or gastroesophageal junction cancers: a plain language summary.
Future Oncol
; : 1-17, 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38861294
5.
Epacadostat Plus Pembrolizumab and Chemotherapy for Advanced Solid Tumors: Results from the Phase I/II ECHO-207/KEYNOTE-723 Study.
Oncologist
; 27(11): 905-e848, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36156099
6.
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(2): 167-192, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130500
7.
Associations of baseline patient-reported outcomes with treatment outcomes in advanced gastrointestinal cancer.
Cancer
; 127(4): 619-627, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33170962
8.
Early Weight Loss as a Prognostic Factor in Patients with Advanced Gastric Cancer: Analyses from REGARD, RAINBOW, and RAINFALL Phase III Studies.
Oncologist
; 26(9): e1538-e1547, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34037286
9.
Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group.
Oncologist
; 26(8): 651-659, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650740
10.
Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma.
Oncologist
; 26(10): e1704-e1729, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34288262
11.
Impact of Treatment Sequencing on Survival for Patients with Locally Advanced Gastric Cancer.
Ann Surg Oncol
; 28(5): 2856-2865, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393043
12.
LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial.
Invest New Drugs
; 39(4): 1057-1071, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624233
13.
Master transcription factors form interconnected circuitry and orchestrate transcriptional networks in oesophageal adenocarcinoma.
Gut
; 69(4): 630-640, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31409603
14.
Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer.
Oncologist
; 25(11): e1671-e1680, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32627883
15.
Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence.
Oncologist
; 25(1): e147-e159, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578273
16.
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers.
Oncologist
; 25(11): e1691-e1700, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32820577
17.
The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA.
Oncologist
; 25(1): e39-e47, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31604903
18.
Case 31-2022: A 72-Year-Old Man with Heartburn, Nausea, and Inability to Eat.
N Engl J Med
; 387(15): 1415-1424, 2022 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239648
19.
Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
Gastroenterology
; 156(8): 2242-2253.e4, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30836094
20.
Initial Report of Second-Line FOLFIRI in Combination with Ramucirumab in Advanced Gastroesophageal Adenocarcinomas: A Multi-Institutional Retrospective Analysis.
Oncologist
; 24(4): 475-482, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30470690